Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase EARLY_PHASE1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Gynecologic 1

Conditions

Peripheral Nervous System Diseases 1Pain 1Ovarian Neoplasms 1Cancer Cachexia 1Breastcancer 1Breast Neoplasms 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 53Saline Solution 49Cyclophosphamide 48Palliative Care 46Yoga 41Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Patient Navigation 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Completed × Omacor × Clear all
NCT01821833 2022-10-05

Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

New Mexico Cancer Research Alliance

Phase NA Completed
60 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms, Pain, Peripheral Nervous System Diseases

NCT02996240 2021-03-17

Breast, Omega 3 Free Fatty Acid, Ph 0

The University of Texas Health Science Center at San Antonio

Phase NA Completed
21 enrolled
Breast

Breastcancer

NCT00815685 2017-03-23

A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
36 enrolled 7 charts

Cancer Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡